INTENSITY THERAPEUTICS, INC. 8-K

What Happened

• Intensity Therapeutics, Inc. filed a Form 8-K on March 23, 2026, disclosing a prospectus supplement that increases the capacity of its existing at-the-market (ATM) offering program to $60.0 million. The ATM is governed by the at-the-market offering agreement dated July 3, 2024 with H.C. Wainwright & Co. LLC as sales agent. The company is not obligated to sell any shares under the program.

Key Details

• ATM capacity increased to an aggregate of $60.0 million of common stock.
• Sales agent: H.C. Wainwright & Co. LLC (per Offering Agreement dated July 3, 2024).
• Use of the ATM is at the company’s discretion and will depend on market conditions, pricing, any limits the company sets, and investor demand.
• The filing includes a legal opinion from Mintz, Levin, Cohn, Ferris, Glovsky & Popeo, P.C. regarding the issuance and sale of the shares.

Why It Matters

• This gives the company a ready mechanism to raise up to $60 million in equity capital quickly if management decides it’s needed, which can be useful for funding operations, R&D, or other corporate needs.
• If and when shares are sold under the ATM, existing shareholders could face dilution; however, there is no commitment the company will sell any shares.
• Retail investors should note the increased fundraising capacity and monitor any future ATM sales announcements, which can affect share supply and market price.